PharmaShots

FEBRUARY 27, 2023

As a renowned chemist, Dr. Senanayake discussed the need to adopt green chemistry in the process of drug development for cost reduction, timely innovation, and generating less waste than the standard process. According to me the main issue faced during the pandemic was the supply chain of pharmaceuticals.

Biosimilars 40

Biosimilars Diabetes Packaging Hospitals 40

European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.

Drug Development 115

Drug Development Immunity Immunization Pharmaceutical Companies 115

PharmaShots

APRIL 10, 2023

Shots: With an incurable nature and hefty medication costs, diabetes mellitus remains a global health concern and the seventh leading cause of death across the world. Moreover, the ceaseless trials of pharmaceutical companies in the research of drugs for several disease conditions have transformed the course of therapeutics.

Diabetes 40

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 40

PharmaShots

MAY 9, 2023

Sit back and relax, while the article unfolds before you, the magic model that is certain to revamp your company Achieving economic sustenance and ensuring smooth sailing even in unfavorable situations are two common dreams that every pharmaceutical company shares.

Pharmaceutical Companies 56

Pharmaceutical Companies Pharmaceutical Companies Drug Development Drug Pricing 56

pharmaphorum

NOVEMBER 2, 2020

A recent study by Kearney revealed that 68% of global industry leaders in the healthcare sector see AI and advanced analytics as major value drivers, indicating most companies are aware of their combined potential. There are exciting developments happening for AI in healthcare – from drug discovery to diagnostics and care delivery.

Vaccines 132

Vaccines Drug Development Diabetes Immunization 132

European Pharmaceutical Review

APRIL 10, 2024

EAPs should therefore be considered both important and complementary to clinical trials, allowing pharmaceutical companies to gain a better understanding of how patients respond to treatments outside of a controlled, clinical environment. Internet] Pharmaceutical Technology. cited 2024Feb].

Immunity 95

Immunity Immunization Chemotherapy Diabetes 95

Pharmaceutical Technology

DECEMBER 22, 2022

The company is a clinical-stage biopharmaceutical startup that uses its artificial intelligence (AI)-enabled platform to measure brain biomarkers, including electroencephalogram (EEG) activity and behavioural patterns, wearable data, genetics and other factors, to drive targeted drug development in mental health. Shortlist.

Diabetes 52

Diabetes Biosimilars Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 27, 2023

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds. So, living with diabetes, living with multiple sclerosis, living with ovarian cancer.” But who is benefitting?

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 111

European Pharmaceutical Review

FEBRUARY 1, 2024

Obesity, metabolic syndrome, diabetes epidemic is global, so that aggravates cardiovascular risk… we are seeing a marked acceleration of heart disease deaths, and we need to find new therapies to make a difference. What are the top three trends impacting the cardiovascular drug development space today?

Documentation 97

Documentation Diabetes Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

FEBRUARY 20, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Diabetes 40

Diabetes Pharmaceutical Companies Pharmaceutical Companies Vaccines 40

The Digital Apothecary

MAY 13, 2017

As a pharmacy educator, I love the history of drug development for instance, and in every discussion, I have with students, whether in the classroom or small groups, I like to frame our current understanding of what we are doing based on what we used to do. Take for example Type I Diabetes (sometimes called Juvenile Diabetes).

Diabetes 130

Diabetes Vaccines Pharmaceutical Companies Pharmaceutical Companies 130